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CD4+ T lymphocytes represent the main target cell
population of human immunodeficiency virus (HIV). In
an activated state, CD4+ T cells residing in lymphoid
organs are a major reservoir of ongoing HIV-1 replica-
tion in infected individuals. In contrast, resting CD4+
T cells are highly resistant to productive HIV-1 infec-
tion, yet are massively depleted during disease progres-
sion and pose a substantial latent reservoir for the virus
in vivo. Barriers preventing replication HIV-1 in resting
CD4+ T cells include a rigid layer of cortical actin and,
early after HIV-1 entry, a block that limits reverse tran-
scription of incoming viral RNA genomes. Defining the
molecular bases of these restrictions has remained one of
the central open questions in HIV research. Recent
advances unraveled mechanisms by which HIV-1 bypasses
the entry block and established the host cell restriction
factor SAMHD1 as a central determinant of the cellular
restriction to HIV-1 reverse transcription in resting CD4+
T cells. Our current molecular and pathophysiological
understanding of the multi-faceted interactions of HIV-1
with resting CD4+ T lymphocytes will be discussed.
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